|
1
|
Kyrle PA and Eichinger S: Clinical scores
to predict recurrence risk of venous thromboembolism. Thromb
Haemost. 108:1061–1064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Becattini C and Manina G: Long-term
treatment of venous thromboembolism. Curr Vasc Pharmacol.
12:384–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogg K, Wells PS and Gandara E: The
diagnosis of venous thromboembolism. Semin Thromb Hemost.
38:691–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pabinger I, Thaler J and Ay C: Biomarkers
for prediction of venous thromboembolism in cancer. Blood.
122:2011–2018. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perry JR: Thromboembolic disease in
patients with high-grade glioma. Neuro Oncol. 14(Suppl 4):
iv73–iv80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mackman N: New insights into the
mechanisms of venous thrombosis. J Clin Invest. 122:2331–2336.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wells PS, Forgie MA and Rodger MA:
Treatment of venous thromboembolism. JAMA. 311:717–728. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kearon C: Long-term anticoagulation for
venous thromboembolism: Duration of treatment and management of
warfarin therapy. Clin Chest Med. 31:719–730. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu T, Martinez I and Emmerich J: Venous
thromboembolism: Risk factors for recurrence. Arterioscler Thromb
Vasc Biol. 29:298–310. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharifi M, Bay C, Schwartz F and Skrocki
L: Safe-dose thrombolysis plus rivaroxaban for moderate and severe
pulmonary embolism: Drip, drug, and discharge. Clin Cardiol.
37:78–82. 2014. View Article : Google Scholar
|
|
11
|
Barabási AL and Oltvai ZN: Network
biology: Understanding the cell's functional organization. Nat Rev
Genet. 5:101–113. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suthram S, Dudley JT, Chiang AP, Chen R,
Hastie TJ and Butte AJ: Network-based elucidation of human disease
similarities reveals common functional modules enriched for
pluripotent drug targets. PLoS Comput Biol. 6:e10006622010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laenen G, Thorrez L, Börnigen D and Moreau
Y: Finding the targets of a drug by integration of gene expression
data with a protein interaction network. Mol Biosyst. 9:1676–1685.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martinelli I, De Stefano V and Mannucci
PM: Inherited risk factors for venous thromboembolism. Nat Rev
Cardiol. 11:140–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Newman RH, Hu J, Rho HS, Xie Z, Woodard C,
Neiswinger J, Cooper C, Shirley M, Clark HM, Hu S, et al:
Construction of human activity-based phosphorylation networks. Mol
Syst Biol. 9:6552013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li L, Tibiche C, Fu C, Kaneko T, Moran MF,
Schiller MR, Li SS and Wang E: The human phosphotyrosine signaling
network: Evolution and hotspots of hijacking in cancer. Genome Res.
22:1222–1230. 2012. View Article : Google Scholar :
|
|
17
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al The Gene Ontology Consortium: Gene ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Magrane M and Consortium U: UniProt
Knowledgebase: A hub of integrated protein data. Database (Oxford).
2011:bar0092011. View Article : Google Scholar
|
|
19
|
Samsa G, Matchar DB, Dolor RJ, Wiklund I,
Hedner E, Wygant G, Hauch O, Marple CB and Edwards R: A new
instrument for measuring anticoagulation-related quality of life:
development and preliminary validation. Health Qual Life Outcomes.
2:222004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lewis DA, Stashenko GJ, Akay OM, Price LI,
Owzar K, Ginsburg GS, Chi JT and Ortel TL: Whole blood gene
expression analyses in patients with single versus recurrent venous
thromboembolism. Thromb Res. 128:536–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reimand J, Tooming L, Peterson H, Adler P
and Vilo J: GraphWeb: Mining heterogeneous biological networks for
gene modules with functional significance. Nucleic Acids Res.
36:W452–W459. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bewick V, Cheek L and Ball J: Statistics
review 10: Further nonparametric methods. Crit Care. 8:196–199.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
24
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
25
|
Curtis RK, Oresic M and Vidal-Puig A:
Pathways to the analysis of microarray data. Trends Biotechnol.
23:429–435. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mukherjee K, Abhipriya, Vidyarthi AS and
Pandey DM: SVM based model generation for binding site prediction
on helix turn helix motif type of transcription factors in
eukaryotes. Bioinformation. 9:500–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bradley AP: The use of the area under the
ROC curve in the evaluation of machine learning algorithms. Pattern
Recognition. 30:1145–1159. 1997. View Article : Google Scholar
|
|
28
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization, and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nojima J, Suehisa E, Kuratsune H, Machii
T, Koike T, Kitani T, Kanakura Y and Amino N: Platelet activation
induced by combined effects of anticardiolipin and lupus
anticoagulant IgG antibodies in patients with systemic lupus
erythematosus - possible association with thrombotic and
thrombocytopenic complications. Thromb Haemost. 81:436–441.
1999.PubMed/NCBI
|
|
30
|
Inanç M, Donohoe S, Ravirajan CT,
Radway-Bright EL, Mackie I, Machin S and Isenberg DA:
Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin
antibodies in a longitudinal study of patients with systemic lupus
erythematosus and the antiphospholipid syndrome. Br J Rheumatol.
37:1089–1094. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Markiewski MM, Nilsson B, Ekdahl KN,
Mollnes TE and Lambris JD: Complement and coagulation: Strangers or
partners in crime? Trends Immunol. 28:184–192. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gawaz M and Vogel S: Platelets in tissue
repair: Control of apoptosis and interactions with regenerative
cells. Blood. 122:2550–2554. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meunier D, Fonlupt P, Saive AL, Plailly J,
Ravel N and Royet JP: Modular structure of functional networks in
olfactory memory. Neuroimage. 95:264–275. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maruyama O: Heterodimeric protein complex
identification by naïve Bayes classifiers. BMC Bioinformatics.
14:3472013. View Article : Google Scholar
|
|
35
|
Azar AT, Elshazly HI, Hassanien AE and
Elkorany AM: A random forest classifier for lymph diseases. Comput
Methods Programs Biomed. 113:465–473. 2014. View Article : Google Scholar
|
|
36
|
Wishart DS, Knox C, Guo AC, Cheng D,
Shrivastava S, Tzur D, Gautam B and Hassanali M: DrugBank: A
knowledgebase for drugs, drug actions and drug targets. Nucleic
Acids Res. 36:D901–D906. 2008. View Article : Google Scholar :
|
|
37
|
Norris LA: Blood coagulation. Best Pract
Res Clin Obstet Gynaecol. 17:369–383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
White MJ and Kile BT: Apoptotic processes
in megakaryocytes and platelets. Semin Hematol. 47:227–234. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Thomé S: ACP Journal Club. Edoxaban was
noninferior to warfarin for preventing recurrent venous
thromboembolism, with less bleeding. Ann Intern Med. 160:JC42014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lane DA, Olds RJ and Thein SL:
Antithrombin III: Summary of first database update. Nucleic Acids
Res. 22:3556–3559. 1994.PubMed/NCBI
|
|
41
|
Hull RD and Gersh MH: The current
landscape of treatment options for venous thromboembolism: A focus
on novel oral anticoagulants. Curr Med Res Opin. 31:197–210. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eikelboom JW, Zelenkofske SL and Rusconi
CP: Coagulation factor IXa as a target for treatment and
prophylaxis of venous thromboembolism. Arterioscler Thromb Vasc
Biol. 30:382–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cripe LD, Moore KD and Kane WH: Structure
of the gene for human coagulation factor V. Biochemistry.
31:3777–3785. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hoyer LW and Hemophilia A: Hemophilia A. N
Engl J Med. 330:38–47. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Geerts WH, Bergqvist D, Pineo GF, Heit JA,
Samama CM, Lassen MR and Colwell CW; American College of Chest
Physicians: Prevention of venous thromboembolism: American College
of Chest Physicians Evidence-Based Clinical Practice Guidelines
(8th Edition). Chest. 133(Suppl 6): 381S–453S. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Abo-Salem E and Becker R: Transitioning to
and from the novel oral anticoagulants: A management strategy for
clinicians. J Thromb Thrombolysis. 37:372–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chee CE, Ashrani AA, Marks RS, Petterson
TM, Bailey KR, Melton LJ III and Heit JA: Predictors of venous
thromboem-bolism recurrence and bleeding among active cancer
patients: A population-based cohort study. Blood. 123:3972–3978.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Deitelzweig SB, Lin J, Kreilick C, Hussein
M and Battleman D: Warfarin therapy in patients with venous
thromboembolism: Patterns of use and predictors of clinical
outcomes. Adv Ther. 27:623–633. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pillai AR, Olujohungbe A, Evans MR, Main
NJ and Hunt BJ: The management of recurrent VTE in cancer patients
receiving therapeutic anticoagulation: The use of dual
anticoagulant therapy combined with an IVC filter. Blood Coagul
Fibrinolysis. 21:766–769. 2010.PubMed/NCBI
|
|
50
|
Akl EA, Kahale L, Barba M, Neumann I,
Labedi N, Terrenato I, Sperati F, Muti P and Schünemann H:
Anticoagulation for the long-term treatment of venous
thromboembolism in patients with cancer. Cochrane Database Syst
Rev. 7:CD0066502014.
|
|
51
|
Schulman S, Kearon C, Kakkar AK, Schellong
S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P and
Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial
Investigators: Extended use of dabigatran, warfarin, or placebo in
venous thromboembolism. N Engl J Med. 368:709–718. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu Y, Qin J, Chen D, Wang H, Wang J and Yu
Y: Chronic cardiovascular disease-associated gene network analysis
in human umbilical vein endothelial cells exposed to
2,3,7,8-tetrachlorodibenzo-p-dioxin. Cardiovasc Toxicol.
15:157–171. 2015. View Article : Google Scholar
|
|
53
|
Freedman JE: Inherited dysfunctional
nitric oxide signaling and the pathobiology of atherothrombotic
disease. Circ Res. 114:1372–1373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zeng Y, Pan Y, Liu H, Kang K, Wu Y, Hui G,
Peng W, Ramchandran R, Raj JU and Gou D: MiR-20a regulates the
PRKG1 gene by targeting its coding region in pulmonary arterial
smooth muscle cells. FEBS Lett. 588:4677–4685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lv W, Duan Q, Wang L, Gong Z, Yang F and
Song Y: Gene expression levels of cytokines in peripheral blood
mononuclear cells from patients with pulmonary embolism. Mol Med
Rep. 7:1245–1250. 2013.PubMed/NCBI
|
